Date | Dividend Yield | Free Cash Flow Yield | Earnings Yield | Enterprise Value (EV) |
---|
CEO | Mr. Gustav Hanghoj Gram |
IPO Date | July 15, 2021 |
Location | Sweden |
Headquarters | VAestergatan 1 |
Employees | 1 |
Sector | Health Care |
Industries |
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Past 5 years
USD 0.13
USD 0.25
StockViz Staff
January 15, 2025
Any question? Send us an email